Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
, 2 (3), 250-2

Effect of acetyl-L-carnitine in the Treatment of Painful Peripheral Neuropathies in HIV+ Patients

Affiliations
  • PMID: 10975731
Clinical Trial

Effect of acetyl-L-carnitine in the Treatment of Painful Peripheral Neuropathies in HIV+ Patients

E Scarpini et al. J Peripher Nerv Syst.

Abstract

We studied the effects of acetyl-L-carnitine on pain in 16 HIV+ patients affected by painful distal symmetrical neuropathy. Patients were treated with 0.5-1 gr per day of acetyl-L-carnitine either i.m. or i.v. for 3 weeks. Pain intensity was measured before and after the treatment by the Huskisson's analogic scale. Ten patients (62.5%) reported an improvement of symptoms, five patients (31.25%) were unchanged, one patient worsened. The results of this open study show that acetyl-L-carnitine can have a role in the treatment of pain in distal symmetrical polyneuropathy related to HIV infection. However, further double-blind, placebo-controlled studies are needed to confirm these preliminary results.

Similar articles

See all similar articles

Cited by 17 PubMed Central articles

See all "Cited by" articles

Publication types

Feedback